Please login to the form below

Not currently logged in
Email:
Password:

ulipristal acetate

This page shows the latest ulipristal acetate news and features for those working in and with pharma, biotech and healthcare.

MHRA suspends new prescriptions of fibroid drug Esmya

MHRA suspends new prescriptions of fibroid drug Esmya

Esmya (ulipristal acetate) is a selective progesterone receptor modulator billed as a safer and more effective pharmacological treatment for uterine fibroids than existing drugs such as AbbVie's Lupron (leuprolide acetate),

Latest news

More from news
Approximately 1 fully matching, plus 9 partially matching documents found.

Latest Intelligence

  • The pill branding The pill branding

    In the UK, Levonelle with the active ingredient levonorgestrel and ellaOne containing ulipristal acetate are sold over the counter to girls over 16 since 2001. ... the binding landmark decision of switching the ellaOne (ulipristal acetate) pill to an OTC

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics